(19)
(11) EP 3 994 127 A1

(12)

(43) Date of publication:
11.05.2022 Bulletin 2022/19

(21) Application number: 20747153.3

(22) Date of filing: 01.07.2020
(51) International Patent Classification (IPC): 
C07D 231/56(2006.01)
C07D 249/18(2006.01)
C07D 277/22(2006.01)
A01N 43/647(2006.01)
A01N 43/82(2006.01)
C07D 235/12(2006.01)
C07D 271/06(2006.01)
C07D 413/04(2006.01)
A01N 43/78(2006.01)
(52) Cooperative Patent Classification (CPC):
C07D 231/56; C07D 235/12; C07D 271/06; C07D 277/22; C07D 249/18; C07D 413/04
(86) International application number:
PCT/IL2020/050732
(87) International publication number:
WO 2021/001825 (07.01.2021 Gazette 2021/01)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 04.07.2019 US 201962870711 P

(71) Applicant: Migal Galilee Research Institute Ltd.
1101602 Kiryat Shmona (IL)

(72) Inventors:
  • BLOCH, Itai
    1383000 Ramot Naftali (IL)
  • GAL, Maayan
    3780800 Givaat Ada (IL)

(74) Representative: Russell, Tim et al
Venner Shipley LLP 200 Aldersgate
London EC1A 4HD
London EC1A 4HD (GB)

   


(54) METHIONINE METABOLIC PATHWAY INHIBITORS